[1]
“INNOVATIVE DIAGNOSTIC TECHNOLOGIES AND TARGETED THERAPEUTICS IN HYPERTROPHIC CARDIOMYOPATHY: IMPLICATIONS FOR PERSONALIZED PATIENT CARE”, IJITSS, vol. 2, no. 4(48), Dec. 2025, doi: 10.31435/ijitss.4(48).2025.4716.